Logo

Medical University of South Carolina

South Carolina Population Genomics Program Marks First Anniversary With Surge in Participation
Premium

The In Our DNA SC partnership between MUSC and Helix is still struggling to match the diversity of the South Carolina population, but outreach is expanding.

Helix, Medical University of South Carolina Partner for Population Genomics Program

The effort plans to enroll 100,000 patients and return genetic findings in order to drive personalized and proactive care and to grow a clinico-genomic database.

Human Microbiome Program at MUSC Shows Early Promise
Premium

Two years in, the MUSC Program for Human Microbiome Research is finding its footing, but it has high ambitions for creating safer care environments.

MUSC Wins NIH Grant to Support Proteogenomics, Bioinformatics Core

The grant will help create the new core as part of the existing South Carolina Center of Biomedical Research Excellence (COBRE) for cardiovascular disease.

Emory Wins Funding for TBI Biomarker Study

The researchers will use an NIH grant to seek protein biomarkers in the blood to predict clinical outcomes of traumatic brain injury.
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.